vip receptor antagonist vip 6–28 Search Results


vip receptor antagonist viphyb  (GL Biochem)
90
GL Biochem vip receptor antagonist viphyb
<t>VIP</t> regulates AM and IFN-α/β responses post-RSV infection. (a) AM percentages at 12 h postinfection in lung tissues of KCF mice with or without <t>VIPhyb</t> treatment. (b) IFN-α/β secretion at 12 h postinfection as measured in BALF samples from KCF mice with or without VIPhyb treatment. (c) AM percentages at 12 h postinfection in lung tissues of intact mice with or without VIP treatment. (d) IFN-α/β secretion at 12 h postinfection as measured in BALF samples from intact mice with or without VIP treatment. *, P < 0.05, and **, P < 0.01, compared with RSV or KCF-RSV group; ## , P < 0.01, and ### , P < 0.001, compared with VIP-RSV group. Data are representative of 2 independent experiments. Error bars show SEM.
Vip Receptor Antagonist Viphyb, supplied by GL Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vip+receptor+antagonist+vip+6%E2%80%9328/vip+receptor+antagonist+viphyb/pmc09769737-148-4-11
Average 90 stars, based on 1 article reviews
vip receptor antagonist viphyb - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
vip receptor antagonist vip 6–28  (Bachem)
90
Bachem vip receptor antagonist vip 6–28
<t>VIP</t> regulates AM and IFN-α/β responses post-RSV infection. (a) AM percentages at 12 h postinfection in lung tissues of KCF mice with or without <t>VIPhyb</t> treatment. (b) IFN-α/β secretion at 12 h postinfection as measured in BALF samples from KCF mice with or without VIPhyb treatment. (c) AM percentages at 12 h postinfection in lung tissues of intact mice with or without VIP treatment. (d) IFN-α/β secretion at 12 h postinfection as measured in BALF samples from intact mice with or without VIP treatment. *, P < 0.05, and **, P < 0.01, compared with RSV or KCF-RSV group; ## , P < 0.01, and ### , P < 0.001, compared with VIP-RSV group. Data are representative of 2 independent experiments. Error bars show SEM.
Vip Receptor Antagonist Vip 6–28, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vip+receptor+antagonist+vip+6%E2%80%9328/vip+6+28/pmc02408801-61-11-16
Average 90 stars, based on 1 article reviews
vip receptor antagonist vip 6–28 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
vip antagonist (sn)viphyb  (Bachem)
90
Bachem vip antagonist (sn)viphyb
<t>VIP</t> regulates AM and IFN-α/β responses post-RSV infection. (a) AM percentages at 12 h postinfection in lung tissues of KCF mice with or without <t>VIPhyb</t> treatment. (b) IFN-α/β secretion at 12 h postinfection as measured in BALF samples from KCF mice with or without VIPhyb treatment. (c) AM percentages at 12 h postinfection in lung tissues of intact mice with or without VIP treatment. (d) IFN-α/β secretion at 12 h postinfection as measured in BALF samples from intact mice with or without VIP treatment. *, P < 0.05, and **, P < 0.01, compared with RSV or KCF-RSV group; ## , P < 0.01, and ### , P < 0.001, compared with VIP-RSV group. Data are representative of 2 independent experiments. Error bars show SEM.
Vip Antagonist (Sn)viphyb, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vip+receptor+antagonist+vip+6%E2%80%9328/vip+antagonist++sn+viphyb/pmc02574685-68-11-14
Average 90 stars, based on 1 article reviews
vip antagonist (sn)viphyb - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
phenylmethylsulfonyl fluoride  (Enamine Ltd)
99
Enamine Ltd phenylmethylsulfonyl fluoride
<t>VIP</t> regulates AM and IFN-α/β responses post-RSV infection. (a) AM percentages at 12 h postinfection in lung tissues of KCF mice with or without <t>VIPhyb</t> treatment. (b) IFN-α/β secretion at 12 h postinfection as measured in BALF samples from KCF mice with or without VIPhyb treatment. (c) AM percentages at 12 h postinfection in lung tissues of intact mice with or without VIP treatment. (d) IFN-α/β secretion at 12 h postinfection as measured in BALF samples from intact mice with or without VIP treatment. *, P < 0.05, and **, P < 0.01, compared with RSV or KCF-RSV group; ## , P < 0.01, and ### , P < 0.001, compared with VIP-RSV group. Data are representative of 2 independent experiments. Error bars show SEM.
Phenylmethylsulfonyl Fluoride, supplied by Enamine Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vip+receptor+antagonist+vip+6%E2%80%9328/Phenylmethylsulfonyl+fluoride/custom%40en300-24380%4022291440
Average 99 stars, based on 1 article reviews
phenylmethylsulfonyl fluoride - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
pacap receptor antagonists  (Tocris)
94
Tocris pacap receptor antagonists
<t>VIP</t> regulates AM and IFN-α/β responses post-RSV infection. (a) AM percentages at 12 h postinfection in lung tissues of KCF mice with or without <t>VIPhyb</t> treatment. (b) IFN-α/β secretion at 12 h postinfection as measured in BALF samples from KCF mice with or without VIPhyb treatment. (c) AM percentages at 12 h postinfection in lung tissues of intact mice with or without VIP treatment. (d) IFN-α/β secretion at 12 h postinfection as measured in BALF samples from intact mice with or without VIP treatment. *, P < 0.05, and **, P < 0.01, compared with RSV or KCF-RSV group; ## , P < 0.01, and ### , P < 0.001, compared with VIP-RSV group. Data are representative of 2 independent experiments. Error bars show SEM.
Pacap Receptor Antagonists, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vip+receptor+antagonist+vip+6%E2%80%9328/PACAP+6-38/pm27816700-75-13-20
Average 94 stars, based on 1 article reviews
pacap receptor antagonists - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


VIP regulates AM and IFN-α/β responses post-RSV infection. (a) AM percentages at 12 h postinfection in lung tissues of KCF mice with or without VIPhyb treatment. (b) IFN-α/β secretion at 12 h postinfection as measured in BALF samples from KCF mice with or without VIPhyb treatment. (c) AM percentages at 12 h postinfection in lung tissues of intact mice with or without VIP treatment. (d) IFN-α/β secretion at 12 h postinfection as measured in BALF samples from intact mice with or without VIP treatment. *, P < 0.05, and **, P < 0.01, compared with RSV or KCF-RSV group; ## , P < 0.01, and ### , P < 0.001, compared with VIP-RSV group. Data are representative of 2 independent experiments. Error bars show SEM.

Journal: Microbiology Spectrum

Article Title: C-Fiber Degeneration Enhances Alveolar Macrophage-Mediated IFN-α/β Response to Respiratory Syncytial Virus

doi: 10.1128/spectrum.02410-22

Figure Lengend Snippet: VIP regulates AM and IFN-α/β responses post-RSV infection. (a) AM percentages at 12 h postinfection in lung tissues of KCF mice with or without VIPhyb treatment. (b) IFN-α/β secretion at 12 h postinfection as measured in BALF samples from KCF mice with or without VIPhyb treatment. (c) AM percentages at 12 h postinfection in lung tissues of intact mice with or without VIP treatment. (d) IFN-α/β secretion at 12 h postinfection as measured in BALF samples from intact mice with or without VIP treatment. *, P < 0.05, and **, P < 0.01, compared with RSV or KCF-RSV group; ## , P < 0.01, and ### , P < 0.001, compared with VIP-RSV group. Data are representative of 2 independent experiments. Error bars show SEM.

Article Snippet: Both VIP and the VIP receptor antagonist VIPhyb were synthesized by GL Biochem Ltd. (Shanghai, China), with purities of >98%.

Techniques: Infection

VIP protects against RSV infection. (a) RSV titers in lung tissues of KCF mice with or without VIPhyb treatment. (b) Representative lung histopathological images and scores of KCF mice with or without VIPhyb treatment. Scale bar = 50 μm. (c) RSV titers in lung tissues of intact mice with or without VIP treatment. (d) Representative lung histopathological images and scores of intact mice with or without VIP treatment. *, P < 0.05, and **, P < 0.01, compared with RSV or KCF-RSV group. Data are representative of 2 independent experiments. Error bars show SEM.

Journal: Microbiology Spectrum

Article Title: C-Fiber Degeneration Enhances Alveolar Macrophage-Mediated IFN-α/β Response to Respiratory Syncytial Virus

doi: 10.1128/spectrum.02410-22

Figure Lengend Snippet: VIP protects against RSV infection. (a) RSV titers in lung tissues of KCF mice with or without VIPhyb treatment. (b) Representative lung histopathological images and scores of KCF mice with or without VIPhyb treatment. Scale bar = 50 μm. (c) RSV titers in lung tissues of intact mice with or without VIP treatment. (d) Representative lung histopathological images and scores of intact mice with or without VIP treatment. *, P < 0.05, and **, P < 0.01, compared with RSV or KCF-RSV group. Data are representative of 2 independent experiments. Error bars show SEM.

Article Snippet: Both VIP and the VIP receptor antagonist VIPhyb were synthesized by GL Biochem Ltd. (Shanghai, China), with purities of >98%.

Techniques: Infection

Sequences of VIPhyb and VIP

Journal: Microbiology Spectrum

Article Title: C-Fiber Degeneration Enhances Alveolar Macrophage-Mediated IFN-α/β Response to Respiratory Syncytial Virus

doi: 10.1128/spectrum.02410-22

Figure Lengend Snippet: Sequences of VIPhyb and VIP

Article Snippet: Both VIP and the VIP receptor antagonist VIPhyb were synthesized by GL Biochem Ltd. (Shanghai, China), with purities of >98%.

Techniques: Sequencing